ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
The Biggest Winners and Losers of JPM 2018
January 18, 2018With the J.P. Morgan Healthcare Conference now over, some analysts are looking back and picking out the “winners and losers” from the conference. CNBC’s Jim Cramer made his picks related to stock performance. -
Array BioPharma (ARRY) Price Target Increased to $13.00 by Analysts at Jefferies Group
December 26, 2017Array BioPharma (NASDAQ:ARRY) had its price objective raised by equities research analysts at Jefferies Group to $13.00 in a note issued to investors on Friday -
MyDx Cancels Reverse Stock Split
December 21, 2017MYDX, a science and technology company and creator of MyDx®, the first multi-use handheld chemical analyzer designed for Cannabis professionals and retail consumers to correlate the chemical profile of cannabis with how it makes them feel and which ailmen -
Argenx Announces Closing of U.S. Public Offering for Gross Proceeds of Approximately $26M
December 20, 2017argenx's ADSs are currently listed on the Nasdaq Global Select Market under the symbol "ARGX," and argenx's ordinary shares are currently listed on Euronext Brussels. -
Allergan embarks on $2 billion share repurchase
September 27, 2017Allergan is to embark on a new $2 billion share repurchase programme – soon after it completed a separate buyback of $15 billion in its own shares.
Pharma Sources Insight January 2025
